Results 131 to 140 of about 63,050 (312)

The CBD Industry: A Silent Growing Giant

, 2023
Chinese Emperor Shen Neng discovered the first cannabidiol (CBD) benefits in 2737 BC. Originally, Emperor Shen Neng used CBD in a medicinal tea to help ease numerous ailments similar to the common uses seen today (Releaf Pharmaceuticals, n.d.).
Adkinson, Sara
core  

Corticocortical evoked potential amplitude is altered by cortical stimulation in epilepsy

Epilepsia, EarlyView.
Abstract Objective Neurostimulation is an established therapy for drug‐resistant epilepsy, but optimizing stimulation parameters remains a major challenge. Corticocortical evoked potential (CCEP) amplitude may serve as an immediate biomarker of neurostimulation effects, enabling rapid parameter optimization.
Bethany J. Stieve, Aaron F. Struck, Dillon Scott, Richard Chappell, Andrew T. Knox   +4 more
wiley   +1 more source

Vízoldható CBD és CBG származékok előállítása és vizsgálata

A CBD és CBG számos kedvező farmakológiai tulajdonságát írták már le, mely révén több betegség esetén potenciális gyógyszerjelöltté válhatnak. A farmakológiai hatásaik közül azonban egyik sem kiemelkedő, emellett a gyógyszerként történő felhasználást ...
Tótik, Angéla
core  

Clinical validation of a patient‐friendly saliva microsampling approach to monitor perampanel levels in people with epilepsy

Epilepsia, EarlyView.
Abstract Perampanel (PER) is a third‐generation antiseizure medication (ASM) with a well‐established concentration–effect relationship. Saliva represents a non‐invasive alternative to plasma for therapeutic drug monitoring (TDM) of PER, as it reflects the free plasma fraction.
Valentina Franco, Francesca Dattrino, Michela Palmisani, Federica Tacchella, Elena Tartara, Valentina De Giorgis, Carlo Alberto Quaranta, Ludovica Pasca, Paola Rota, Emilio Russo, Andrea Romigi, Cecilie Johannessen Landmark, Guido Fedele, Cristina Tassorelli, Pierluigi Nicotera   +14 more
wiley   +1 more source

South African retail pharmacists’ knowledge of cannabidiol and cannabis, and training recommendations

South African Family Practice
Background: With the evolving legal landscape in South Africa, cannabidiol (CBD) and non-medical cannabis products are increasingly available, posing challenges for healthcare professionals.
Yugeshnee Naik, Naushaad Ebrahim
doaj   +1 more source

Thoroughfares and Apartment Values [PDF]

While the monocentric urban models were once adequate for predicting the declining rent gradients for North American cities, the advent of a transportation system with major arteries such as turnpikes, thoroughfares and commuter rails has distorted the ...
Forrest E. Huffman, Paul K. Asabere
core  

Hypersensitivity reaction risk when restarting cenobamate after discontinuation: Insights from a prolonged hospitalized cohort

Epilepsia Open, EarlyView.
Abstract Objective To evaluate the risk of hypersensitivity reactions, including dermatological rashes, when cenobamate (CNB) is restarted at maintenance doses after temporary discontinuation. Methods We leveraged the natural experiment of long antiseizure medication discontinuation during intracranial EEG evaluation and conducted a retrospective ...
Marina Feldman, Andreas Alexopoulos, Juan Bulacio, Dileep Nair, Vineet Punia   +4 more
wiley   +1 more source

CBD: Coffee Beans Dataset

Data in Brief
The development of advanced coffee bean classification techniques depends on the availability of high quality datasets. Coffee bean quality is influenced by various factors, including bean size, shape, colour, and defects such as fungal damage, full black, full sour, broken beans, and insect damage.
Bipin Nair B．J, Abrav Nanda K．M, Shalwin A．S, V. Raghavendra   +3 more
openaire   +2 more sources

Cannabidiol reduces atypical absence seizures and epileptic spasms in a Gabrb3+/D120N mouse model of Lennox–Gastaut syndrome

Epilepsia Open, EarlyView.
Abstract Objective Lennox–Gastaut syndrome (LGS) is a drug‐resistant developmental and epileptic encephalopathy (DEE). Preclinical drug development for LGS is constrained by a lack of syndrome‐relevant animal models. We aimed to evaluate a Gabrb3+/D120N knock‐in (KI) mouse model of LGS by quantifying atypical absence seizures and epileptic spasms and ...
Thomas Harman, Laura A. Sharman, Ka Lai Yip, Miguel Bedoya‐Pérez, Vaishali Janve, Jonathon C. Arnold   +5 more
wiley   +1 more source

Correction: Potency and safety analysis of hemp delta-9 products: the hemp vs. cannabis demarcation problem

Journal of Cannabis Research, 2023
Lee Johnson, Marc Malone, Erik Paulson, Josh Swider, David Marelius, Susan Andersen, Dominic Black   +6 more
doaj   +1 more source